Sorbonne Université, INSERM, Saint-Antoine Research Center (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
Sorbonne Université, INSERM, Saint-Antoine Research Center (CRSA), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Hepatology Department, Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis, Paris, France.
Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3688-3696. doi: 10.1016/j.bbadis.2018.10.008. Epub 2018 Oct 4.
Portal myofibroblasts (PMF) form a sub-population of highly proliferative and proangiogenic liver myofibroblasts that derive from portal mesenchymal progenitors. Endoplasmic reticulum (ER) stress was previously shown to modulate fibrogenesis, notably in the liver. Our aim was to determine if ER stress occurred in PMF and affected their functions. PMF were obtained after their expansion in vivo from bile duct-ligated (BDL) rats and referred to as BDL PMF. Compared to standard PMF obtained from normal rats, BDL PMF were more myofibroblastic, as assessed by higher alpha-smooth muscle actin expression and collagen 1 production. Their proangiogenic properties were also higher, whereas their proliferative and migratory capacities were lower. CHOP expression was detected in the liver of BDL rats, at the leading edge of portal fibrosis where PMF accumulate. BDL PMF displayed ER dilatation and an overexpression of the PERK pathway downstream targets, Chop, Gadd34 and Trb3, in comparison with standard PMF. In vitro, the induction of ER stress by tunicamycin in standard PMF, caused a decrease in their proliferative and migratory activity, and an increase in their proangiogenic activity, without affecting their myofibroblastic differentiation. Conversely, the treatment of BDL PMF with the PERK inhibitor GSK2656157 reduced ER stress, which caused a decrease in their angiogenic properties, and restored their proliferative and migratory capacity. In conclusion, PMF develop ER stress as they expand with the progression of fibrosis, which further increases their proangiogenic activity, but also inhibits their proliferation and migration. This phenotypic switch may restrict PMF expansion while they support angiogenesis.
门脉肌成纤维细胞(PMF)是一类具有高度增殖和促血管生成能力的肝肌成纤维细胞亚群,来源于门脉间质祖细胞。内质网(ER)应激先前被证明可以调节纤维化,特别是在肝脏中。我们的目的是确定 ER 应激是否发生在 PMF 中,并影响它们的功能。PMF 是从胆管结扎(BDL)大鼠体内扩增后获得的,并称为 BDL PMF。与从正常大鼠获得的标准 PMF 相比,BDL PMF 具有更高的肌成纤维细胞特征,表现为更高的α-平滑肌肌动蛋白表达和胶原 1 产生。它们的促血管生成特性也更高,而增殖和迁移能力则更低。在 BDL 大鼠的肝脏中检测到 CHOP 的表达,在门脉纤维化的前沿,PMF 聚集于此。与标准 PMF 相比,BDL PMF 显示 ER 扩张和 PERK 通路下游靶点 Chop、Gadd34 和 Trb3 的过度表达。在体外,用衣霉素诱导标准 PMF 的 ER 应激导致其增殖和迁移活性降低,促血管生成活性增加,而不影响其肌成纤维细胞分化。相反,用 PERK 抑制剂 GSK2656157 处理 BDL PMF 可减少 ER 应激,从而降低其血管生成特性,并恢复其增殖和迁移能力。总之,PMF 在纤维化进展过程中扩张时会发生 ER 应激,这进一步增加了它们的促血管生成活性,但也抑制了它们的增殖和迁移。这种表型转换可能限制了 PMF 的扩张,同时支持了血管生成。